Treatment of children with acute promyelocytic leukemia: Results of the first North American intergroup trial INT0129

This report focuses on the children enrolled on the first North American Intergroup study of APL (INT0129). This study was designed to compare the rates of CR, disease‐free survival (DFS), overall survival (OS) and toxicity of therapy with all‐trans‐retinoic acid (ATRA) for remission induction and/or maintenance compared to conventional chemotherapy in patients with previously untreated APL.

[1]  B. Powell.  Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710 , 2007 .

[2]  E. Estey,et al.  Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. , 2006, Blood.

[3]  B. George,et al.  Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. , 2006, Blood.

[4]  R. Arceci,et al.  Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891 , 2005, Leukemia.

[5]  S. Raimondi,et al.  Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000 , 2005, Leukemia.

[6]  Marcos González,et al.  Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R. Foà,et al.  GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. , 2005, Blood.

[8]  W. Abdullah.  Pediatr Blood Cancer , 2004 .

[9]  A. Baruchel,et al.  Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Yuan-fang Liu,et al.  All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Bloomfield,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol , 2022 .

[12]  X. Thomas,et al.  Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia , 2002, Annals of Hematology.

[13]  E. Estey,et al.  Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia. , 2002, Blood.

[14]  L. Degos,et al.  All trans retinoic acid in acute promyelocytic leukemia , 2001 .

[15]  D. Reinhardt,et al.  Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children , 2001, Annals of Hematology.

[16]  H. Dombret,et al.  Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia , 2000, Leukemia.

[17]  P. Zubizarreta,et al.  CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA: No Benefit of All-trans-Retinoic Acid Administered in a Short-Course Schedule , 2000, Pediatric hematology and oncology.

[18]  P. Kadam,et al.  All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia. , 1998, Pediatric hematology and oncology.

[19]  A. Bartolucci,et al.  Long‐term follow‐up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia , 1997, Cancer.

[20]  H. Mugishima,et al.  [Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group]. , 1997, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[21]  J. Krischer,et al.  Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood , 1996 .

[22]  H. Dombret,et al.  All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. , 1992, Blood.

[23]  M. Tallman,et al.  Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. , 1992, Blood.

[24]  C. Bloomfield,et al.  Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Yacoub,et al.  CARDIAC TRANSPLANTATION FOR DOXORUBICIN‐INDUCED CARDIOMYOPATHY IN ACUTE MYELOID LEUKAEMIA , 1990, British journal of haematology.

[26]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[27]  J. Rowley,et al.  Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. , 1984, The American journal of medicine.

[28]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[30]  P. Fenaux,et al.  All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. , 1990, Blood.

[31]  H. Kantarjian,et al.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[32]  H. Dombret,et al.  Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. , 2000, Leukemia.

[33]  J. Krischer,et al.  Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. , 1996, The New England journal of medicine.

[34]  Suzanne,et al.  Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. , 1992, Blood.